RXRX Recursion Pharmaceuticals Inc

USD 5.75 -0.29 ( -4.80)%
Icon

Recursion Pharmaceuticals Inc (RXRX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 5.75

-0.29 (-4.80)%

USD 1.85B

0.01B

USD 11.50(+100.00%)

USD 11.00 (+91.30%)

Icon

RXRX

Recursion Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 5.75
-0.29 ( -4.80)%
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 1.85B

USD 11.00 (+91.30%)

USD 5.75

Recursion Pharmaceuticals Inc (RXRX) Stock Forecast

Show ratings and price targets of :
USD 11.50
(+100.00%)

Based on the Recursion Pharmaceuticals Inc stock forecast from 5 analysts, the average analyst target price for Recursion Pharmaceuticals Inc is USD 11.50 over the next 12 months. Recursion Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Recursion Pharmaceuticals Inc is Bearish, which is based on 2 positive signals and 7 negative signals. At the last closing, Recursion Pharmaceuticals Inc’s stock price was USD 5.75. Recursion Pharmaceuticals Inc’s stock price has changed by -16.79% over the past week, -14.94% over the past month and -12.08% over the last year.

No recent analyst target price found for Recursion Pharmaceuticals Inc
No recent average analyst rating found for Recursion Pharmaceuticals Inc

Company Overview Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops ...Read More

https://www.recursion.com

41 South Rio Grande Street, Salt Lake City, UT, United States, 84101

500

December

USD

USA

Adjusted Closing Price for Recursion Pharmaceuticals Inc (RXRX)

Loading...

Unadjusted Closing Price for Recursion Pharmaceuticals Inc (RXRX)

Loading...

Share Trading Volume for Recursion Pharmaceuticals Inc Shares

Loading...

Compare Performance of Recursion Pharmaceuticals Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for RXRX

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Recursion Pharmaceuticals Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -0.86 (-0.19%) USD121.60B 32.57 250.99

Frequently Asked Questions About Recursion Pharmaceuticals Inc (RXRX) Stock

Based on ratings from 5 analysts Recursion Pharmaceuticals Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 5 buy, sell and 3 hold ratings.

Unfortunately we do not have enough data on RXRX's stock to indicate if its a good dividend stock.

Based on targets from 5 analysts, the average taret price for RXRX is USD 11.50 over the next 12 months. The maximum analyst target price is USD 17 while the minimum anlayst target price is USD 6.

Unfortunately we do not have enough data on RXRX's stock to indicate if its overvalued.

The last closing price of RXRX's stock was USD 5.75.

The most recent market capitalization for RXRX is USD 1.85B.

Based on targets from 5 analysts, the average taret price for RXRX is projected at USD 11.50 over the next 12 months. This means that RXRX's stock price may go up by +100.00% over the next 12 months.

We can't find any ETFs which contains Recursion Pharmaceuticals Inc's stock.

As per our most recent records Recursion Pharmaceuticals Inc has 500 Employees.

Recursion Pharmaceuticals Inc's registered address is 41 South Rio Grande Street, Salt Lake City, UT, United States, 84101. You can get more information about it from Recursion Pharmaceuticals Inc's website at https://www.recursion.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About Recursion Pharmaceuticals Inc (RXRX) Stock

Based on ratings from 5 analysts Recursion Pharmaceuticals Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 5 buy, sell and 3 hold ratings.

Unfortunately we do not have enough data on RXRX's stock to indicate if its a good dividend stock.

Based on targets from 5 analysts, the average taret price for RXRX is USD 11.50 over the next 12 months. The maximum analyst target price is USD 17 while the minimum anlayst target price is USD 6.

Unfortunately we do not have enough data on RXRX's stock to indicate if its overvalued.

The last closing price of RXRX's stock was USD 5.75.

The most recent market capitalization for RXRX is USD 1.85B.

Based on targets from 5 analysts, the average taret price for RXRX is projected at USD 11.50 over the next 12 months. This means that RXRX's stock price may go up by +100.00% over the next 12 months.

We can't find any ETFs which contains Recursion Pharmaceuticals Inc's stock.

As per our most recent records Recursion Pharmaceuticals Inc has 500 Employees.

Recursion Pharmaceuticals Inc's registered address is 41 South Rio Grande Street, Salt Lake City, UT, United States, 84101. You can get more information about it from Recursion Pharmaceuticals Inc's website at https://www.recursion.com.
Loading...